Safety Emporium eyewashes
Safety Emporium eyewashes

Interactive Learning Paradigms, Incorporated

DCHAS-L Discussion List Archive

About This Archive  |   DCHAS-L 2023 Index   |   DCHAS-L Yearly Index   |   DCHAS-L Home Page

About This Archive

DCHAS-L 2023 Index

DCHAS-L Yearly Index

DCHAS-L Home Page


Previous by Date

Subject: Re: [DCHAS-L] Raman?

Date: Apr 19, 2023 22:02 UTC

Author: Jack Reidy <jreidy2**At_Symbol_Here**STANFORD.EDU>

Next by Date

Subject: Re: [DCHAS-L] EPA proposes new rules to cut ethylene oxide exposure

Date: Apr 19, 2023 23:12 UTC

Author: pzavon**At_Symbol_Here**ROCHESTER.RR.COM

From: Craig Merlic <merlic**At_Symbol_Here**CHEM.UCLA.EDU>

Subject: Re: [DCHAS-L] Novel Compounds in Animal Research

Date: Apr 19, 2023 22:15 UTC

Reply-To: ACS Division of Chemical Health and Safety <DCHAS-L**At_Symbol_Here**Princeton.EDU>

Message-ID: <AC5365AF-D193-4088-8233-CF4A281D2CCA**At_Symbol_Here**chem.ucla.edu>

In-Reply-To:  

Demystify: 

Steve,

 

Testing novel compounds in animals is common, but as you say, the toxicological properties of the compounds (drugs) may not be fully assessed at the time.  So a key question could be: what are the hazards of the animal feces, urine and bedding?

 

This was examined with tamoxifen and bromodeoxyuridine and it was found that the compounds were essentially fully metabolized within 72 hours. This is only one study, but is an approach.

 

The research was done by Nancy Wayne through the Center for Laboratory Safety:

Exposure assessment of laboratory workers to hazardous waste from mice treated with tamoxifen and bromodeoxyuridineJournal of Chemical Health and Safety

Volume 26, Issue 1, January–February 2019, Pages 2-8.  https://doi.org/10.1016/j.jchas.2018.08.003

 

Best,

Craig

 

Craig A. Merlic

Professor of Chemistry, UCLA Department of Chemistry and Biochemistry

Executive Director, UC Center for Laboratory Safety

http://cls.ucla.edu

Los Angeles, CA  90095-1569

Voice:  310-825-5466

 

From: ACS Division of Chemical Health and Safety <DCHAS-L**At_Symbol_Here**Princeton.EDU> on behalf of Stephen Beaton <Steve.Beaton**At_Symbol_Here**DAL.CA>
Reply-To: ACS Division of Chemical Health and Safety <DCHAS-L**At_Symbol_Here**Princeton.EDU>
Date: Wednesday, April 19, 2023 at 2:02 PM
To: <DCHAS-L**At_Symbol_Here**Princeton.EDU>
Subject: [DCHAS-L] Novel Compounds in Animal Research

 

Hello everyone,

 

How are other groups evaluating the safety requirements for the use of novel compounds in animal research? Our primary concern is that researchers are conducting animal studies with compounds that do not have safety data. Thus, the toxicity of the compound and/or its metabolites are unknown, and it unclear what is required to safely work with the treated animals and what to do if someone is exposed.

 

Does anyone have access to relevant expertise to assist with developing a policy for the safe use of novel compounds in animal research?

 

Any info or help is much appreciated!

 

Thank you,

Steve

 

Stephen Beaton, MSc, CHO, CRSP 
CHEMICAL SAFETY MANAGER

Environmental Health and Safety Office
1435 Seymour Street
PO Box 15000 | Halifax, NS  B3H 4R2  Canada
902.494.1934 | steve.beaton**At_Symbol_Here**dal.ca

DALHOUSIE UNIVERSITY
dal.ca/safety

 

 

--- For more information about the DCHAS-L e-mail list, contact the Divisional membership chair at membership**At_Symbol_Here**dchas.org

Previous post  |  Top of Page  |  Next post